MedPath

Open-label Extension Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

Phase 3
Recruiting
Conditions
Hypercholesterolemia
Interventions
Registration Number
NCT06492291
Lead Sponsor
Merck Sharp & Dohme LLC
Brief Summary

This is an extension study to evaluate the longer-term safety and efficacy of enlicitide decanoate in adults with hypercholesterolemia who completed either study MK-0616-013 (NCT05952856), study MK-0616-017 (NCT05952869), or study MK-0616-018 (NCT06450366).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • Has completed an enlicitide decanoate parent study [MK-0616-013 (NCT05952856), MK-0616-017 (NCT05952869), and MK-0616-018 (NCT Number pending)] per protocol (including the final assessments/procedures of their parent study)
  • Had an overall study intervention compliance ≥80% while participating in their parent study
Exclusion Criteria
  • Has discontinued study intervention in their parent study
  • Has an ongoing serious adverse event considered related to study intervention by the investigator in the parent study
  • Is currently participating in an interventional clinical study other than an enlicitide decanoate parent study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Enlicitide DecanoateEnlicitide DecanoateParticipants will receive 20 mg of enlicitide decanoate orally once daily (QD)
Primary Outcome Measures
NameTimeMethod
Number of participants with one or more adverse events (AEs)Up to approximately 3 years

An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.

Number of participants who discontinue study drug due to an AEUp to approximately 3 years

An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.

Secondary Outcome Measures
NameTimeMethod
Mean percent change from baseline of the parent study in non-high-density lipoprotein cholesterol (non-HDL-C) at Week 8 of this Extension StudyBaseline of the parent study and Week 8 of this extension study

The percent change from baseline in Non-HDL-C. Each participant's baseline data from their parent study will be used as baseline data for this analysis.

Percent change from baseline of the parent study in lipoprotein(a) (Lp[a]) at Week 8 of this extension studyBaseline of the parent study and Week 8 of this extension study

The percent change from baseline in Lp(a). Each participant's baseline data from their parent study will be used as baseline data for this analysis.

Mean percent change from baseline of the parent study in LDL-C at Week 8 of this extension studyBaseline of the parent study and Week 8 of this extension study

The percent change from baseline in LDL-C. Each participant's baseline data from their parent study will be used as baseline data for this analysis.

Mean percent change from baseline of the parent study in apolipoprotein B (ApoB) at Week 8 of this extension studyBaseline of the parent study and Week 8 of this extension study

The percent change from baseline in apolipoprotein B. Each participant's baseline data from their parent study will be used as baseline data for this analysis.

Percentage of participants with LDL-C <70 mg/dL and ≥50% reduction from baseline of the parent studyBaseline in the parent study and up to approximately 3 years in this extension study

The percentage of participants who have LDL-C \<70 mg/dL and ≥50% reduction from baseline at any point during the study. Each participant's baseline data from their parent study will be used as baseline data for this analysis.

Percentage of participants with LDL-C <55 mg/dL and ≥50% reduction from baseline of the parent studyBaseline in the parent study and up to approximately 3 years in this extension study

The percentage of participants who have LDL-C \<55 mg/dL and ≥50% reduction from baseline at any point during the study. Each participant's baseline data from their parent study will be used as baseline data for this analysis.

Trial Locations

Locations (222)

Rambam Health Care Campus ( Site 1742)

🇮🇱

Haifa, Israel

Alliance for Multispecialty Research, LLC ( Site 0027)

🇺🇸

Daphne, Alabama, United States

G&L Research ( Site 0035)

🇺🇸

Foley, Alabama, United States

Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0048)

🇺🇸

Phoenix, Arizona, United States

Chengdu Second Municipal People's Hospital ( Site 6032)

🇨🇳

Chengdu, Sichuan, China

National Heart Institute-Research ( Site 0029)

🇺🇸

Beverly Hills, California, United States

Clinical Trials Research ( Site 0054)

🇺🇸

Sacramento, California, United States

Velocity Clinical Research, Banning ( Site 0023)

🇺🇸

San Bernardino, California, United States

Emerson Clinical Research Institute ( Site 0017)

🇺🇸

Washington, District of Columbia, United States

Excel Medical Clinical Trials ( Site 0010)

🇺🇸

Boca Raton, Florida, United States

Alliance for Multispecialty Research, LLC ( Site 0037)

🇺🇸

Coral Gables, Florida, United States

Alliance for Multispecialty Research, LLC ( Site 0056)

🇺🇸

Fort Myers, Florida, United States

Shaare Zedek Medical Center ( Site 1735)

🇮🇱

Jerusalem, Israel

Velocity Clinical Research, Hallandale Beach ( Site 0053)

🇺🇸

Hallandale Beach, Florida, United States

Jacksonville Center for Clinical Research ( Site 0025)

🇺🇸

Jacksonville, Florida, United States

South Broward Research ( Site 0012)

🇺🇸

Miramar, Florida, United States

Progressive Medical Research ( Site 0033)

🇺🇸

Port Orange, Florida, United States

Clinical Research Trials of Florida ( Site 0006)

🇺🇸

Tampa, Florida, United States

Clinical Site Partners, LLC dba Flourish Research ( Site 0004)

🇺🇸

Winter Park, Florida, United States

East Coast Institute for Research, LLC ( Site 0020)

🇺🇸

Macon, Georgia, United States

Healthcare Research Network - Chicago ( Site 0051)

🇺🇸

Flossmoor, Illinois, United States

Synexus Clinical Research US - Evansville ( Site 0005)

🇺🇸

Evansville, Indiana, United States

Midwest Institute For Clinical Research ( Site 0052)

🇺🇸

Indianapolis, Indiana, United States

Alliance for Multispecialty Research, LLC ( Site 0001)

🇺🇸

Lexington, Kentucky, United States

L-MARC Research Center ( Site 0011)

🇺🇸

Louisville, Kentucky, United States

Velocity Clinical Research, Covington ( Site 0026)

🇺🇸

Covington, Louisiana, United States

Velocity Clinical Research Rockville ( Site 0022)

🇺🇸

Rockville, Maryland, United States

Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0018)

🇺🇸

Troy, Michigan, United States

Velocity Clinical Research, Gulfport ( Site 0032)

🇺🇸

Gulfport, Mississippi, United States

Healthcare Research Network - St. Louis ( Site 0040)

🇺🇸

Hazelwood, Missouri, United States

Velocity Clinical Research at The Pioneer Heart Institute, Lincoln ( Site 0031)

🇺🇸

Lincoln, Nebraska, United States

Jubilee Clinical Research ( Site 0049)

🇺🇸

Las Vegas, Nevada, United States

AB Clinical Trials ( Site 0002)

🇺🇸

Las Vegas, Nevada, United States

Hadassah Medical Center ( Site 1732)

🇮🇱

Jerusalem, Israel

New Mexico Clinical Research & Osteoporosis Center ( Site 0043)

🇺🇸

Albuquerque, New Mexico, United States

Velocity Clinical Research, Syracuse ( Site 0014)

🇺🇸

East Syracuse, New York, United States

Icahn School of Medicine at Mount Sinai-Cardiology ( Site 0042)

🇺🇸

New York, New York, United States

Lillestol Research ( Site 0030)

🇺🇸

Fargo, North Dakota, United States

altoona center for clinical research ( Site 0024)

🇺🇸

Duncansville, Pennsylvania, United States

Cardiology Consultants of Philadelphia Yardley ( Site 0021)

🇺🇸

Yardley, Pennsylvania, United States

Velocity Clinical Research, Anderson ( Site 0015)

🇺🇸

Anderson, South Carolina, United States

Piedmont Research Partners ( Site 0045)

🇺🇸

Fort Mill, South Carolina, United States

Coastal Carolina Research Center ( Site 0055)

🇺🇸

North Charleston, South Carolina, United States

Monument Health Clinical Research, a department of Monument -Monument Health Clinical Research, a d

🇺🇸

Rapid City, South Dakota, United States

Holston Medical Group ( Site 0034)

🇺🇸

Kingsport, Tennessee, United States

Alliance for Multispecialty Research, LLC ( Site 0050)

🇺🇸

Knoxville, Tennessee, United States

Velocity Clinical Research, Dallas ( Site 0028)

🇺🇸

Dallas, Texas, United States

Center for Cardiometabolic Disease Prevention/Baylor College of Medicine ( Site 0009)

🇺🇸

Houston, Texas, United States

Clinical Trials of Texas, LLC ( Site 0016)

🇺🇸

San Antonio, Texas, United States

Synexus Clinical Research US, Inc. ( Site 0003)

🇺🇸

Salt Lake City, Utah, United States

Velocity Clinical Research, Salt Lake City ( Site 0041)

🇺🇸

West Jordan, Utah, United States

Manassas Clinical Research Center ( Site 0007)

🇺🇸

Manassas, Virginia, United States

Health Research of Hampton Roads, Inc. ( Site 0019)

🇺🇸

Newport News, Virginia, United States

Alliance for Multispecialty Research, LLC ( Site 0008)

🇺🇸

Norfolk, Virginia, United States

National Clinical Research, Inc ( Site 0044)

🇺🇸

Richmond, Virginia, United States

Rainier Clinical Research Center ( Site 0013)

🇺🇸

Renton, Washington, United States

CEDIC ( Site 0603)

🇦🇷

Caba, Buenos Aires, Argentina

Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada ( Site 0605)

🇦🇷

Caba, Buenos Aires, Argentina

Fundación Respirar ( Site 0606)

🇦🇷

Caba, Buenos Aires, Argentina

Instituto de Investigaciones Clínicas Mar del Plata ( Site 0602)

🇦🇷

Mar del Plata, Buenos Aires, Argentina

Instituto de Investigaciones Clinicas Zarate ( Site 0604)

🇦🇷

Zárate, Buenos Aires, Argentina

Fundacion Estudios Clinicos ( Site 0601)

🇦🇷

Rosario, Santa Fe, Argentina

Centro de Investigaciones Metabolicas CINME - Cardiology ( Site 0607)

🇦🇷

Caba, Argentina

CIPREC ( Site 0600)

🇦🇷

Caba, Argentina

Royal Prince Alfred Hospital-6West CV Ambulatory Care ( Site 2808)

🇦🇺

Camperdown, New South Wales, Australia

Victorian Heart Hospital-Monash Cardiovascular Research Centre (MCRC) ( Site 2803)

🇦🇺

Clayton, Victoria, Australia

Universidade Federal Do Ceara ( Site 0702)

🇧🇷

Fortaleza, Ceara, Brazil

Instituto Dante Pazzanese de Cardiology ( Site 0701)

🇧🇷

São Paulo, Sao Paulo, Brazil

Incor - Instituto do Coracao ( Site 0703)

🇧🇷

Sao Paulo, Brazil

The Medical Arts Health Research Group ( Site 0506)

🇨🇦

North Vancouver, British Columbia, Canada

Cambridge Cardiac Care Centre ( Site 0502)

🇨🇦

Cambridge, Ontario, Canada

North York Diagnostic and Cardiac Centre ( Site 0505)

🇨🇦

North York, Ontario, Canada

Ecogene-21 ( Site 0500)

🇨🇦

Chicoutimi, Quebec, Canada

Institut de Cardiologie de Montreal ( Site 0504)

🇨🇦

Montreal, Quebec, Canada

Diex Recherche Trois-Rivieres ( Site 0503)

🇨🇦

Trois-Rivieres, Quebec, Canada

Clinical Research Chile SpA ( Site 0800)

🇨🇱

Valdivia, Los Rios, Chile

CDIEM ( Site 0801)

🇨🇱

Providencia, Region M. De Santiago, Chile

Pontificia Universidad Catolica de Chile-CICUC ( Site 0803)

🇨🇱

Santiago, Region M. De Santiago, Chile

Beijing Anzhen Hospital, Capital Medical University-Cardiovascular ( Site 6000)

🇨🇳

Beijing, Beijing, China

Beijing Friendship Hospital Affiliate of Capital University ( Site 6003)

🇨🇳

Beijing, Beijing, China

The Second Affiliated Hospital of Chongqing Medical University ( Site 6020)

🇨🇳

Chongqing, Chongqing, China

Chongqing University Three Gorges Hospital ( Site 6021)

🇨🇳

Chongqing, Chongqing, China

Guangdong Provincial People s Hospital ( Site 6004)

🇨🇳

Guangzhou, Guangdong, China

Zhujiang Hospital ( Site 6029)

🇨🇳

Guangzhou, Guangdong, China

Huizhou Municipal Central Hospital ( Site 6079)

🇨🇳

Huizhou, Guangdong, China

The University of Hong Kong-Shenzhen Hospital ( Site 6018)

🇨🇳

Shenzhen, Guangdong, China

Jingzhou Central Hospital ( Site 6076)

🇨🇳

Jingzhou, Hubei, China

Wuhan Fourth Hospital ( Site 6056)

🇨🇳

Wuhan, Hubei, China

Hunan Provincial People's Hospital ( Site 6017)

🇨🇳

Changsha, Hunan, China

Changzhou Second People's Hospital ( Site 6073)

🇨🇳

Changzhou, Jiangsu, China

Northern Jiangsu People s Hospital ( Site 6008)

🇨🇳

Yangzhou, Jiangsu, China

The Third Hospital of Nanchang - Fuhe ( Site 6078)

🇨🇳

Nanchang, Jiangxi, China

Siping Central People's Hospital ( Site 6011)

🇨🇳

Siping, Jilin, China

Xianyang Hospital of Yan'an University ( Site 6040)

🇨🇳

Xianyang City, Shaanxi, China

Lishui City People s Hospital ( Site 6002)

🇨🇳

Lishui, Zhejiang, China

Fundación Centro de Investigación Clínica CIC ( Site 0904)

🇨🇴

Medellín, Antioquia, Colombia

Ciensalud Ips S A S ( Site 0900)

🇨🇴

Barranquilla, Atlantico, Colombia

Clinica de la Costa S.A.S. ( Site 0901)

🇨🇴

Barranquilla, Atlantico, Colombia

Salud SURA Calle 100 ( Site 0905)

🇨🇴

Bogotá, Cundinamarca, Colombia

Healthy Medical Center S.A.S ( Site 0902)

🇨🇴

Zipaquira, Cundinamarca, Colombia

Fundación Valle del Lili ( Site 0903)

🇨🇴

Cali, Valle Del Cauca, Colombia

Fakultni Nemocnice u sv. Anny v Brne ( Site 3604)

🇨🇿

Brno, Brno-mesto, Czechia

Fakultní nemocnice Brno Bohunice-Interni kardiologicka klinika ( Site 3602)

🇨🇿

Brno, Brno-mesto, Czechia

Institut Klinicke a Experimentalni Mediciny ( Site 3601)

🇨🇿

Prague, Praha 4, Czechia

Meilahden tornisairaala - Meilahti Tower Hospital ( Site 1300)

🇫🇮

Helsinki, Uusimaa, Finland

Hôpital Arnaud de Villeneuve - CHU Montpellier ( Site 5002)

🇫🇷

Montpellier, Herault, France

Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes ( Site 5004)

🇫🇷

Saint-Herblain, Loire-Atlantique, France

Hospices Civils de Lyon - Hopital Louis Pradel-Service d'endocrinologie, de diabétologie et des mal

🇫🇷

Bron, Rhone, France

Unterfrintroper Hausarztzentrum Klinische Forschung ( Site 1543)

🇩🇪

Essen, Nordrhein-Westfalen, Germany

Hausarzt- und Diabetologische Schwerpunktpraxis Hohenmölsen - Weiβenfels ( Site 1528)

🇩🇪

Hohenmoelsen, Sachsen-Anhalt, Germany

Universitaetsklinikum Carl Gustav Carus Dresden-Universitätsstudienzentrum für Stoffwechselerkranku

🇩🇪

Dresden, Sachsen, Germany

Zentralklinik Bad Berka ( Site 1531)

🇩🇪

Bad Berka, Thuringen, Germany

Velocity Clinical Research GmbH Berlin ( Site 1503)

🇩🇪

Berlin, Germany

Charite Universitätsmedizin Berlin Campus Benjamin Franklin ( Site 1534)

🇩🇪

Berlin, Germany

Queen Mary Hospital-Medical ( Site 3300)

🇭🇰

Hksar, Hong Kong

Prince of Wales Hospital ( Site 3304)

🇭🇰

Shatin, Hong Kong

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Belgyógyászati Klinika ( Site 1603)

🇭🇺

Szeged, Csongrad, Hungary

Semmelweis Egyetem-Városmajori Szív- és Érgyógyászati Klinika ( Site 1600)

🇭🇺

Budapest, Hungary

Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Anyagcsere Tanszék) ( Site 1601)

🇭🇺

Debrecen, Hungary

Hillel Yaffe Medical Center ( Site 1731)

🇮🇱

Hadera, Israel

Rambam Health Care Campus ( Site 1739)

🇮🇱

Haifa, Israel

Hadassah Medical Center ( Site 1741)

🇮🇱

Jerusalem, Israel

Hadassah Medical Center-Heart Institute ( Site 1734)

🇮🇱

Jerusalem, Israel

Meir Medical Center. ( Site 1737)

🇮🇱

Kfar Saba, Israel

Rabin Medical Center ( Site 1738)

🇮🇱

Petah Tikva, Israel

Rabin Medical Center ( Site 1740)

🇮🇱

Petah Tikva, Israel

Sheba Medical Center ( Site 1733)

🇮🇱

Ramat Gan, Israel

Clalit Health Services - Sakhnin Community Clinic ( Site 1730)

🇮🇱

Sakhnin, Israel

Yitzhak Shamir Medical Center. ( Site 1736)

🇮🇱

Zerifin, Israel

Fondazione Policlinico Tor Vergata ( Site 1809)

🇮🇹

Rome, Lazio, Italy

Centro Cardiologico Monzino ( Site 1804)

🇮🇹

Milan, Milano, Italy

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino ( Site 1801)

🇮🇹

Torino, Piemonte, Italy

Azienda Ospedaliera Sant'Andrea-Department of Clinical and Molecular Medicine ( Site 1807)

🇮🇹

Rome, Roma, Italy

Azienda Ospedaliera Garibaldi ( Site 1810)

🇮🇹

Catania, Italy

Hirohata Naika Clinic ( Site 3513)

🇯🇵

Kitakyushu, Fukuoka, Japan

Nakakinen clinic ( Site 3510)

🇯🇵

Naka, Ibaraki, Japan

Noritake Clinic ( Site 3512)

🇯🇵

Ushiku, Ibaraki, Japan

National Hospital Organization Kanazawa Medical Center ( Site 3508)

🇯🇵

Kanazawa, Ishikawa, Japan

Hirano Medical Clinic ( Site 3522)

🇯🇵

Morioka, Iwate, Japan

Shirai Healthcare Clinic Izumichuou ( Site 3527)

🇯🇵

Sendai, Miyagi, Japan

Rinku General Medical Center ( Site 3503)

🇯🇵

Izumisano, Osaka, Japan

Shiraiwa Medical Clinic ( Site 3514)

🇯🇵

Kashiwara, Osaka, Japan

Medical Corporation Heishinkai OCROM Clinic ( Site 3501)

🇯🇵

Suita-shi, Osaka, Japan

Saitama Medical University Hospital ( Site 3506)

🇯🇵

Iruma, Saitama, Japan

Teramoto Medical and Dental Clinic ( Site 3507)

🇯🇵

Bunkyo-ku, Tokyo, Japan

Tokyo-Eki Center-building Clinic ( Site 3505)

🇯🇵

Chuo-ku, Tokyo, Japan

Fukuwa Clinic ( Site 3504)

🇯🇵

Chuo-ku, Tokyo, Japan

Teikyo University Hospital ( Site 3500)

🇯🇵

Itabashi-ku, Tokyo, Japan

Kato Clinic of Internal Medicine ( Site 3509)

🇯🇵

Katsushika-ku, Tokyo, Japan

Kanno Naika ( Site 3511)

🇯🇵

Mitaka, Tokyo, Japan

Sugawara Clinic ( Site 3519)

🇯🇵

Nerima-ku, Tokyo, Japan

Shin Clinic ( Site 3517)

🇯🇵

Ota-ku, Tokyo, Japan

Medical Corporation Heishinkai ToCROM Clinic ( Site 3502)

🇯🇵

Shinjuku-ku, Tokyo, Japan

Medical Corporation Hakuaikai Wellness Tenjin Clinic ( Site 3520)

🇯🇵

Fukuoka, Japan

Hiroshima City Hiroshima Citizens Hospital ( Site 3518)

🇯🇵

Hiroshima, Japan

Mishuku Hospital ( Site 3524)

🇯🇵

Tokyo, Japan

Mitsukoshi Health and Welfare Foundation ( Site 3521)

🇯🇵

Tokyo, Japan

Chungbuk National University Hospital ( Site 3011)

🇰🇷

Cheongju-si, Chungbuk, Korea, Republic of

Wonju Severance Christian Hospital ( Site 3008)

🇰🇷

Wonju, Kang-won-do, Korea, Republic of

Chonnam National University Hospital ( Site 3014)

🇰🇷

Gwangju-si, Kwangju-Kwangyokshi, Korea, Republic of

Seoul National University Bundang Hospital ( Site 3005)

🇰🇷

Seongnam, Kyonggi-do, Korea, Republic of

Ajou University Hospital ( Site 3006)

🇰🇷

Suwon, Kyonggi-do, Korea, Republic of

Dong-A University Hospital-Cardiology ( Site 3013)

🇰🇷

Busan, Pusan-Kwangyokshi, Korea, Republic of

Pusan National University Hospital-Internal Medicine ( Site 3012)

🇰🇷

Busan, Pusan-Kwangyokshi, Korea, Republic of

Inje University Haeundae Paik Hospital ( Site 3010)

🇰🇷

Haeundae-gu, Pusan-Kwangyokshi, Korea, Republic of

Keimyung University Dongsan Hospital CRC room 1 ( Site 3003)

🇰🇷

Daegu, Taegu-Kwangyokshi, Korea, Republic of

Seoul National University Hospital ( Site 3001)

🇰🇷

Seoul, Korea, Republic of

Kangbuk Samsung Hospital ( Site 3009)

🇰🇷

Seoul, Korea, Republic of

Severance Hospital, Yonsei University Health System ( Site 3002)

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center ( Site 3004)

🇰🇷

Seoul, Korea, Republic of

Samsung Medical Center-cardiology ( Site 3000)

🇰🇷

Seoul, Korea, Republic of

The Catholic Univ. of Korea Seoul St. Mary's Hospital-cardiology ( Site 3007)

🇰🇷

Seoul, Korea, Republic of

Instituto Nacional de Ciencias Medicas y Nutricion Salvador -Unidad de Investigación de Enfermedade

🇲🇽

Mexico City, Distrito Federal, Mexico

Instituto Jalisciense de Investigacion en Diabetes y Obesidad-Endocrinology ( Site 1057)

🇲🇽

Guadalajara, Jalisco, Mexico

Radboudumc-internal medicine ( Site 1952)

🇳🇱

Nijmegen, Gelderland, Netherlands

Amsterdam UMC, locatie AMC-Vascular Medicine Clin Trial Unit ( Site 1954)

🇳🇱

Amsterdam, Noord-Holland, Netherlands

Dijklander Ziekenhuis ( Site 1953)

🇳🇱

Hoorn, Noord-Holland, Netherlands

Universitair Medisch Centrum Utrecht-Vascular Medicine Research ( Site 1955)

🇳🇱

Utrecht, Netherlands

Pacific Clinical Research Network - Rotorua ( Site 2902)

🇳🇿

Rotorua, Bay Of Plenty, New Zealand

New Zealand Clinical Research (Christchurch) ( Site 2901)

🇳🇿

Christchurch, Canterbury, New Zealand

Nordlandssykehuset ( Site 2041)

🇳🇴

Bodø, Nordland, Norway

Oslo Universitetssykehus Aker-Lipidklinikken ( Site 2040)

🇳🇴

Oslo, Norway

Changi General Hospital ( Site 3211)

🇸🇬

Singapore, Central Singapore, Singapore

IATROS International ( Site 2204)

🇿🇦

Bloemfontein, Free State, South Africa

Charlotte Maxeke Johannesburg Academic Hospital ( Site 2202)

🇿🇦

Johannesburg, Gauteng, South Africa

Soweto Clinical Trials Centre ( Site 2203)

🇿🇦

Soweto, Gauteng, South Africa

TREAD Research ( Site 2201)

🇿🇦

Cape Town, Western Cape, South Africa

Tiervlei Trial Centre ( Site 2205)

🇿🇦

Cape Town, Western Cape, South Africa

University of Cape Town (UCT)-Medicine, Division of Lipidology ( Site 2200)

🇿🇦

Cape Town, Western Cape, South Africa

Hospital Universitario Virgen de la Victoria-UGC Endocrinologia y nutricion ( Site 2358)

🇪🇸

Malaga, Andalucia, Spain

EBA CENTELLES ( Site 2319)

🇪🇸

Centelles, Barcelona, Spain

Hospital Universitari Vall d'Hebron ( Site 2362)

🇪🇸

Barcelona, Cataluna, Spain

Hospital de Figueres ( Site 2361)

🇪🇸

Figueres, Gerona, Spain

Hospital Abente y Lago ( Site 2356)

🇪🇸

A Coruña, La Coruna, Spain

Hospital San Rafael de Coruna ( Site 2363)

🇪🇸

A Coruña, La Coruna, Spain

CHUS - Hospital Clinico Universitario-Cardiology - Clinical Research Unit ( Site 2320)

🇪🇸

Santiago de compostela, La Coruna, Spain

Hospital Universitario Fundacion ALcorcon-Endocrinologia y Nutrición ( Site 2316)

🇪🇸

Alcorcón, Madrid, Comunidad De, Spain

HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 2344)

🇪🇸

Pozuelo de Alarcon, Madrid, Spain

Vithas Hospital Sevilla-Unidad de Salud Metabólica. Diabetes y Obesidad ( Site 2349)

🇪🇸

Castilleja de la Cuesta, Sevilla, Spain

Hospital Universitari Sant Joan de Reus ( Site 2329)

🇪🇸

Reus, Tarragona, Spain

HOSPITAL CLINICO DE VALENCIA-CARDIOLOGY ( Site 2321)

🇪🇸

Valencia, Valenciana, Comunitat, Spain

EAP Sardenya ( Site 2357)

🇪🇸

Barcelona, Spain

Hospital Universitario 12 de Octubre-Internal Medicine. Unidad de Ensayos Clínicos ( Site 2311)

🇪🇸

Madrid, Spain

Hospital Universitario Virgen Macarena-Cardiology ( Site 2352)

🇪🇸

Sevilla, Spain

Changhua Christian Hospital ( Site 3101)

🇨🇳

Changhua County, Changhua, Taiwan

Chang Gung Memorial Hospital at Kaohsiung ( Site 3102)

🇨🇳

Kaohsiung Niao Sung Dist, Kaohsiung, Taiwan

Mackay Memorial Hospital -Tamsui Branch ( Site 3109)

🇨🇳

New Taipei City, New Taipei, Taiwan

Chi Mei Medical Center ( Site 3104)

🇨🇳

Tainan City, Tainan, Taiwan

Shin Kong Wu Ho-Su Memorial Hospital ( Site 3110)

🇨🇳

Taipei City, Taipei, Taiwan

National Cheng Kung University Hospital-Internal Medicine ( Site 3107)

🇨🇳

Tainan, Taiwan

National Taiwan University Hospital ( Site 3100)

🇨🇳

Taipei, Taiwan

Taipei Medical University Hospital ( Site 3108)

🇨🇳

Taipei, Taiwan

Taipei Veterans General Hospital ( Site 3106)

🇨🇳

Taipei, Taiwan

Chang Gung Medical Foundation-Linkou Branch ( Site 3105)

🇨🇳

Taoyuan, Taiwan

Ege Universitesi Hastanesi-Cardilogy Department ( Site 2502)

🇹🇷

Bornova, Izmir, Turkey

Hacettepe Universite Hastaneleri ( Site 2500)

🇹🇷

Ankara, Turkey

Ankara Bilkent Şehir Hastanesi-cardiology ( Site 2501)

🇹🇷

Ankara, Turkey

Eskisehir Osmangazi University-Cardiology ( Site 2510)

🇹🇷

Eskisehir, Turkey

Erciyes Universitesi Tıp Fakultesi Hastaneleri ( Site 2522)

🇹🇷

Kayseri, Turkey

Kocaeli Üniversitesi-Cardiology ( Site 2516)

🇹🇷

Kocaeli, Turkey

Barts Health NHS Trust-William Harvey Clinical Research Centre ( Site 4001)

🇬🇧

London, England, United Kingdom

Royal Free Hospital ( Site 4000)

🇬🇧

London, England, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath